Skip to main content

Chakkarin Burudpakdee, PharmD

Principal, IMS Health, Fairfax, VA, and Research Assistant Professor, University of North Carolina at Charlotte
Principal, IMS Health, Fairfax, VA, and Research Assistant Professor, University of North Carolina at Charlotte
Authored Items
Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Atheer A. Kaddis, PharmD, Chakkarin Burudpakdee, PharmD, Anshul Shah, BS Pharm, MS, Vijay N Joish, PhD, Christine H. Divers, PhD, Avin Yaldo, PhD
December 2014 Vol 7, No 9 in Practice Management
Last modified: December 23, 2014